Cannabis Technology



Recreational marijuana legalization tied to decline in teens using pot, study says

Recreational marijuana legalization tied to decline in teens using pot, study says

(CNN)Marijuana use among young people in the United States overall has climbed in recent years, but a new paper suggests that in states where recreational marijuana has been legalized, marijuana use among youth may actually be falling. Laws that legalized recreational marijuana were associated with an 8% drop in the number of high schoolers who said they used marijuana in the last 30 days, and a 9% drop in the number who said they'd used at least 10 times in the last 30 days, according to the paper published in the medical journal JAMA Pediatrics on Monday. "Just to be clear we found no effect on teen use following legalization for medical purposes, but evidence of a possible reduction in use following legalization for recreational purposes," said Mark Anderson, an associate professor at Montana State University in Bozeman, Montana, who was first author of the paper. "Because our study is based on more policy variation than prior work, we view our estimates as the most credible to date in the literature," he said.
Scientists Sue DEA Over Marijuana Cultivation Application Delay

Scientists Sue DEA Over Marijuana Cultivation Application Delay

A group of researchers recently filed a lawsuit against the Drug Enforcement Administration (DEA), asking a federal court to force the agency to respond to its application to manufacture marijuana for research purposes. The researchers argued that cannabis produced by the only federally authorized cultivation facility at the University of Mississippi is of poor quality and inadequate for their clinical trial on the use of marijuana to treat post-traumatic stress disorder among veterans. It’s an argument that’s supported by a recent study, which found that cannabis from the sole approved source is genetically closer to hemp than it is to marijuana that’s available to consumers in state-legal markets—calling into question the applicability of much research to the reality of the cannabis market.
Lawmakers File Three Congressional Bills To Help Small Marijuana Businesses

Lawmakers File Three Congressional Bills To Help Small Marijuana Businesses

Small marijuana businesses would be eligible for a wide range of federal economic services under three congressional bills that were filed on Thursday. Following a House Small Business Committee hearing on opportunities and challenges for small cannabis companies earlier this month, the chair and two other members of the panel filed legislation aimed at resolving some of the issues that were raised. One bill, from Chairwoman Nydia Velázquez (D-NY), would allow marijuana businesses to access resources from the federal Small Business Administration (SBA). Those resources include microloans, disaster assistance and the loan guaranty program. The congresswoman said her proposal, which is titled the Ensuring Safe Capital Access for All Small Businesses Act, is meant to support social equity in the cannabis industry.
Congress Schedules Hearing To Discuss Ending Marijuana Prohibition

Congress Schedules Hearing To Discuss Ending Marijuana Prohibition

A major congressional subcommittee will hold a hearing on marijuana policy next week, Marijuana Moment has learned. Though few details about the meeting are currently available, the House Judiciary Crime, Terrorism and Homeland Security Subcommittee is expected to discuss various legislative proposals to allow states to set their own cannabis policies without fear of federal intervention. Several sources who did not wish to be be identified shared with Marijuana Moment the names of witnesses expected to soon receive formal invitations to testify before the panel on Wednesday, July 10. Given the backgrounds of these individuals, it seems apparent that committee members will be discussing not whether the U.S. should end federal cannabis prohibition, but will focus primarily on how to do it.
The Cannabis Equity Con

The Cannabis Equity Con

On June 25, Illinois became the 11th state to legalize marijuana. Governor J.B. Pritzker claims what really sets Illinois’s law apart is that it is the “most equity-centric” legalization law yet. According to Democratic state Representative Jehan Gordon-Booth, this means that “the communities that have suffered through the war on drugs will now have an opportunity to enter a new market and be successful.” This vision of equity, though, is based on a deeply flawed understanding of what a mature legal marijuana market will look like.
Bipartisan Senators Introduce Marijuana And CBD Research Bill

Bipartisan Senators Introduce Marijuana And CBD Research Bill

A bipartisan group of lawmakers introduced a bill on Thursday that’s meant to promote federally authorized research into marijuana and its derivatives like CBD. It was one of several pieces of new congressional cannabis legislation to be filed on the same day. Sens. Dianne Feinstein (D-CA), Brian Schatz (D-HI) and Chuck Grassley (R-IA) are leading the bill, which would streamline the application process for researchers interested in studying the plant, encourage the development of Food and Drug Administration (FDA)-approved drugs derived from marijuana and clarify that doctors can discuss the benefits of cannabis with patients.
FDA Begins Evaluating Cannabis Scientifically

FDA Begins Evaluating Cannabis Scientifically

The Food and Drug Administration says it knows there’s demand for cannabis products, but says it's taking a “science-based” approach to determine their safety and efficacy as it considers how to handle their legality. The FDA recently opened a public docket on cannabis and cannabis-infused products and held its first-ever hearings as it starts the process of figuring out if, and what, it will regulate in the cannabis space. In a message posted on the FDA website, the agency signaled an open-mindedness to the potentially beneficial effects of cannabis and cannabis-derived substances. Cannabidiol, or CBD, is the principal ingredient in one FDA-approved drug, seizure drug Epidiolex, already. But the agency urged the public to understand its interest in analyzing evidence.
Maine’s Cannabis Stores Will (Finally!) Open in 2020

Maine’s Cannabis Stores Will (Finally!) Open in 2020

Cannabis sales are coming to Maine—nearly three years after state voters passed a legalization law back in 2016. Legislators in Augusta on Thursday finally approved a legal framework that will allow the state’s long-delayed retail cannabis stores to open. Gov. Janet Mills is expected to sign the measure, which would allow the first stores to come online in early spring 2020. Since 2016, cannabis has been legal to possess but not to purchase in Maine. The yearslong holdup has been largely thanks to former Gov. Paul LePage, an ardent legalization opponent who did all he could to slow-walk the implementation of the voter initiative. Mills, LePage’s successor who took office earlier this year, has vowed to move ahead with a legal, regulated, taxed cannabis market.
US House OKs Plan to Block Federal Cannabis Interference

US House OKs Plan to Block Federal Cannabis Interference

WASHINGTON (AP) — The Democratic-controlled U.S. House of Representatives has voted to block the Justice Department from interfering with states that have legalized marijuana for adult use. The bipartisan 267-165 vote represents a breakthrough for advocates of legalizing cannabis, who have unsuccessfully pressed the idea in the past under GOP control of the House. Although 11 states have legalized marijuana for personal use, possessing and selling the drug remains a federal offense. Lawmakers have already enacted protections for the 47 states where medical marijuana is legal in some form or another.
Congressional Committee Advances Psychedelics Amendment But Blocks Marijuana Proposal

Congressional Committee Advances Psychedelics Amendment But Blocks Marijuana Proposal

A powerful House Committee cleared a drug policy reform amendment for consideration on the House floor on Monday. But at the same time, it blocked a separate marijuana reform proposal from advancing. The measure moving to a full House vote, introduced by Rep. Alexandria Ocasio-Cortez (D-NY), would eliminate a long-standing rider on a spending bill that prohibits federal agencies from using funds for “any activity that promotes the legalization of any drug or other substance in Schedule I” of the Controlled Substances Act. The congresswoman argued in a summary of her proposal that the current provision impedes valuable research into substances that have therapeutic potential such as psilocybin and MDMA. Cannabis is also listed among those substances as a Schedule I drug.
Questions?
Click here to chat with us

_